R C M Technologies Inc
NASDAQ:RCMT

Watchlist Manager
R C M Technologies Inc Logo
R C M Technologies Inc
NASDAQ:RCMT
Watchlist
Price: 20.06 USD 0.8% Market Closed
Market Cap: $148.6m

R C M Technologies Inc
Investor Relations

RCM Technologies, Inc. engages in the provision of business and technology solutions. The company is headquartered in Pennsauken, New Jersey and currently employs 3,880 full-time employees. The firm operates through three segments: Engineering, Specialty Health Care and Information Technology Services. Its Engineering segment provides engineering and design services, technical writing and digital documentation across marine, locomotive, transportation and aerospace markets, and engineering, procurement and construction management (EPC), as well as demand side management/energy conservation services. The specialty health care segment provides staffing solutions of health care professionals, nurses, paraprofessionals, physicians and therapists and teletherapy services. The Information Technology (IT), segment provides enterprise business solutions, application services, infrastructure solutions, life sciences solutions and other vertical specific offerings.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Record Backlog: RCM Technologies reported a record engineering backlog for 2026, showing strong momentum heading into next year.

Healthcare Growth: The Healthcare segment saw notable growth, with school revenue up 20.7% and a strong start to Q4, despite softer-than-expected summer demand.

Energy Services Outperformance: The Energy Services unit continues to deliver robust results, with backlog for 2026 now over $70 million, up sharply from $21 million at this time last year.

Cost Headwinds: Excess medical costs remained elevated, totaling $800,000 in Q3 and $1.8 million year-to-date, with no significant relief expected in Q4.

Financial Performance: Q3 gross profit rose 8.8% to $19.4 million, while adjusted EBITDA slipped 1.4% to $5.5 million; adjusted EPS held steady at $0.42.

Q4 Outlook: Management expects Q4 to deliver the highest quarterly gross profit and adjusted EBITDA for fiscal 2025.

Key Financials
Gross Profit
$19.4 million
Adjusted EBITDA
$5.5 million
Adjusted EPS
$0.42
Healthcare Gross Profit
$9.0 million
Healthcare Gross Margin
30.0%
School Revenue
$24.4 million
Non-school Revenue
$5.6 million
Engineering Gross Profit
$6.9 million
Engineering Gross Margin
22.0%
Energy Services Backlog for 2026
$70 million
Life Sciences & Data Solutions Gross Profit
$3.5 million
Life Sciences & Data Solutions Gross Margin
39.5%
Excess Medical Costs (Q3)
$800,000
Excess Medical Costs (Year-to-date)
$1.8 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Bradley S. Vizi CFA
Executive Chairman & President
No Bio Available
Mr. Kevin D. Miller
CFO, Treasurer & Secretary
No Bio Available
Mr. Michael Saks
Division President of Health Care Services
No Bio Available
Mr. William D. Gargano
Group Senior Vice President of IT & Life Sciences Services
No Bio Available
Ms. Christine Ciocca
Executive Vice President of Aerospace & Defense
No Bio Available
Mr. Peter Grossman
Senior Vice President of Energy Services Division
No Bio Available

Contacts

Address
NEW JERSEY
Pennsauken
2500 McClellan Ave Ste 350
Contacts
+18563564500.0
www.rcmt.com